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Abstract
Background: Psychosocial stress is becoming a major contributor to increased mental ill-health and sick leave in many
countries. Valid markers of chronic stress would be valuable for diagnostic and prognostic purposes. A recent study
suggested monocyte chemotactic protein-1 (MCP-1), epidermal growth factor (EGF) and vascular endothelial growth factor
(VEGF) as markers of chronic stress. We aimed to confirm these potential biomarkers of prolonged psychosocial stress in
female patients.
Methodology/Principal Findings: Circulating levels of MCP-1, EGF and VEGF, along with several other cytokines, were
measured in plasma from 42 female patients suffering from exhaustion due to prolonged psychosocial stress and 42 control
subjects, using a protein biochip immunoassay. There were no significant differences between patients and controls in any
of the cytokines or growth factors analyzed. Furthermore, when using a different protein bioassay and reanalyzing MCP-1
and VEGF in the same samples, markedly different levels were obtained. To further explore if inflammation is present in
patients with exhaustion, the classical inflammatory marker C-reactive protein (CRP) was measured in another group of
patients (n=89) and controls (n=88) showing a small but significant increase of CRP levels in the patients.
Conclusions/Significance: MCP-1, EGF and VEGF may not be suitable markers of prolonged psychosocial stress as
previously suggested. Furthermore, significant differences were obtained when using two different protein assays
measuring the same samples, indicating that comparing studies where different analytic techniques have been used might
be difficult. Increased levels of CRP indicate that low-grade inflammation might be present in patients with exhaustion due
to prolonged stress exposure but this inflammation does not seem to be reflected by increase in circulating MCP-1 or other
cytokines measured.
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Introduction
Increased long-term sick leave is a substantial problem in many
countries, and a major reason for this increase is generally believed
to be related to psychosocial stress [1,2,3]. This increase is more
pronounced among women, and factors including high demands,
increased work load, changes in the organisation and psycholog-
ical harassment are believed to contribute to the increased stress-
related mental health problems in the working population [1].
Burnout is one of several mental health variables defined as a
psychological outcome of long term stress, and emotional
exhaustion is thought to be an important manifestation of burnout
[4,5]. Vital exhaustion is another term often used to define the
mental health consequences of prolonged psychosocial stress [6].
Work-related stress is also associated with common mental ill-
health such as depression and anxiety [7].
The biological consequences of chronic stress exposure leading
to mental ill-health such as burnout or exhaustion are still not well
known. Many studies focus on the hypothalamus-pituitary-adrenal
(HPA) axis and different cortisol measurements [8] and the
question remains how other biological systems might be affected.
One interesting aspect of biological consequences of prolonged
stress is low-grade inflammation. Inflammatory markers such as C-
reactive protein (CRP) and interleukin-6 are associated with
depression [9], and inflammatory processes have been suggested to
be an important link between psychosocial stress and cardiovas-
cular diseases such as atherosclerosis [10].
Asberg and co-workers recently showed that monocyte
chemotactic protein-1 (MCP-1) is elevated in female patients with
stress-related mental disorders when compared to healthy controls
[11]. MCP-1 is a chemokine with important immune functions,
such as the recruitment of monocytes into the arterial wall,
promoting atherosclerosis [12]. Epidermal growth factor (EGF)
and vascular endothelial growth factor (VEGF) were also shown to
be elevated in the patients studied by Asberg and co-workers [11].
This promising data raises the question if these markers can be
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called for more research to confirm their findings. Therefore, the
present study was designed as an attempt to confirm if the
suggested markers (MCP-1, EGF and VEGF) are elevated in
patients with stress-related exhaustion. We also measured the
more common marker of inflammation CRP in a different group
of patients with stress-related exhaustion.
Materials and Methods
Subjects and Diagnostic Procedures
All patients included in this study where referred to an
outpatient clinic at the Institute of Stress Medicine (ISM) located
in Gothenburg, Sweden. The patients were ambulatory at the time
of the study and none had received inpatient care due to their
illness. They were referred from primary care units or occupa-
tional health care centres from the western part of Sweden and the
referral criteria was 1) ‘‘probable Exhaustion Disorder’’ with no
apparent somatic disorder or abuse that could explain the
exhaustion and 2) a maximal duration of sick leave of six months.
Healthy control subjects were recruited from an ongoing
longitudinal cohort study of the Va ¨stra Go ¨taland Region (mainly
health care workers and social insurance officers) and from
advertisements in daily newspapers.
The first part of the study (cytokines and growth hormone
measurements) involves female patients with stress-related exhaus-
tion (n=42) and healthy female controls (n=42). Of the patients,
52% were on full time sick-leave and 21% where on part-time
sick-leave.
A senior physician at the clinic carried out a diagnostic procedure
of the patients, obtaining an extended anamnesis with a clinical
examination. The DSM-IV based instrument PRIME-MD (one
page patient questionnaire) was filled in by the patient and the
results were used as a support in the diagnostic procedure.
Whenever necessary this included a structured interview to identify
any presence of mood and/or anxiety disorders. To obtain a
relatively homogenous population of patients regarding stress-
related exhaustion the diagnostic criteria for exhaustion disorder
(ED) was used as inclusion criteria (Table 1). Thus all patients
fulfilled the ED criteria, 74% also fulfilled the diagnostic criteria for
depression and 64% for an anxiety disorder. Characteristics of the
participants included in this part are shown in Table 2.
The exclusion criteria for both patients and healthy controls were
known systematic or psychiatric disease (except depression, anxiety
and exhaustion for the patients), present infection, pregnancy,
breast-feeding, oral contraceptives containing oestrogen, any
medication with systemic effects (except for antidepressants for the
patients), body mass index below 18.5 or over 30 kg/m
2,
vitamin B12 deficiency, thyroid disorders or over-consumption of
alcohol. Thirty-one percent (n=13) of the patients were using
antidepressant medication and ten patients and four controls
reported use of nicotine.
Subjects (CRP Measurements)
In a second part of the study, CRP was measured in serum from
89 patients and 88 healthy controls, recruited and diagnosed in the
same manner as described above using the same inclusion/
exclusion criteria, thus all patients shared the feature of fulfilling
the clinical criteria for ED. In this second group, 73% of the
patients also fulfilled the diagnostic criteria for depression and
75% for anxiety disorder. The characteristics of the patients and
healthy controls included in this part of the study are shown in
Table 3. Thirty-three percent (n=29) of the patients where on
antidepressants when blood samples were taken.
Table 1. Diagnostic criteria for Exhaustion Disorder according
to The National Insurance Board in Sweden.
A Physical and mental symptoms of exhaustion with minimum two
weeks duration. The symptoms have developed in response to one
or more identifiable stressors which have been present for at least 6
months.
B Markedly reduced mental energy, which is manifested by reduced
initiative, lack of endurance, or increase of time needed for recovery
after mental efforts.
C At least four of the following symptoms have been present most of
the day, nearly every day, during the same 2-week period:
1 Persistent complaints of impaired memory.
2 Markedly reduced capacity to tolerate demands or to work under time
pressure.
3 Emotional instability or irritability.
4 Insomnia or hypersomnia.
5 Persistent complaints of physical weakness or fatigue.
6 Physical symptoms such as muscular pain, chest pain, palpitations,
gastrointestinal problems, vertigo or increased sensitivity to sounds.
D The symptoms cause clinically significant distress or impairment in
social, occupational or other important areas of functioning.
E The symptoms are not due to the direct physiological effects of a
substance (e.g. a drug of abuse, a medication) or a general medical
condition (e.g. hypothyroidism, diabetes, infectious disease).
F If criteria for major depressive disorder, dysthymic disorder or
generalized anxiety disorder are met, exhaustion disorder is set a
co-morbid condition.
doi:10.1371/journal.pone.0007659.t001
Table 2. Descriptive data of patients and healthy controls, all
females, included in the first part of the study (cytokine and
growth factors measurements).
Patients
(n=42)
Controls
(n=42) p-value
Age (years)
¤ 42.169.4 42.767.5 0.664
BMI (kg/m
2)
¤ 23.163.0 23.462.6 0.371
Burnout score
¤ 5.460.81 2.661.22 ,0.001
- Percent scoring .4.3 on burnout 88% 13%
Percent with depression 74% 0%
(clinical diagnoses)
Percent with anxiety 64% 0%
(clinical diagnoses)
HAD Depression Score
# ,0.001
0–6 36% 91%
7–10 36% 2%
.10 29% 7%
HAD Anxiety Score
# ,0.001
0–6 5% 74%
7–10 21% 14%
.10 74% 12%
¤Mann-Whitney test, data presented as mean and SD.
#Chi-square test, data presented as percentage within each scoring group.
doi:10.1371/journal.pone.0007659.t002
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The study was approved by The Regional Ethical Review
Board in Gothenburg, Sweden and was conducted according to
the Helsinki Declaration. All subjects included in the study gave
written informed consent.
Exhaustion Disorder Criteria
According to the International Classification of Diseases (ICD-
10), burnout is categorized as ‘‘Problems related to life-
management difficulty’’, but other than that, burnout syndrome
is not a clinical defined illness. In order for physicians to better
define people suffering from stress-related disease with pro-
nounced mental and physical exhaustion, The National Insurance
Board in Sweden recently proposed a clinical diagnostic criteria
that could be used in clinical practice, referred to as ‘‘Exhaustion
Disorder’’ (ED). The ICD-10 code F43.8 is used for this diagnose
in clinical practice. To be diagnosed with ED it is required that the
physician together with the patient is able to identify one or more
stressors that have been present for at least six months, during
which time the symptoms have developed. The criteria do not
specify the type or intensity of the stress exposure but it is implicit
that it should be significant enough to provoke the stress
symptoms. The physician goes through the complete ED
diagnostic criteria (Table 1) with the patient. A and B are
obligatory criteria as well as the presence of at least four of six
symptoms listed under C. Also, the condition should cause
significant distress and/or impairment of important areas of
functioning (D) and no symptoms should be due to direct
physiological effects of a substance or a general medical condition
(E). Finally, if the patient does meet the criteria for major
depressive disorder, dysthymic disorder or generalised anxiety
disorder, these diagnoses are set first and ED is set as a co-morbid
condition. In this study special attention is held to chronic fatigue
syndrome, and fibromyalgia sharing some common symptoms
with ED and those patients where excluded from this study.
Self-Rated Anxiety and Depression
The Hospital Anxiety and Depression (HAD) scale was used to
assess self-reported depression and anxiety in both patients and
controls. It was originally developed for non-psychiatric clinics to
detect states of depression and anxiety [13] and the scale has been
found to perform well in assessing cases of anxiety disorders and
depression in different patients population as well as in the general
population [14]. Scores 0–6 are defined as non-cases, 7–10 are
defined as possible cases and score above 10 on each respective
subscale are defined as cases.
Burnout
Self-reported burnout was evaluated in this study using The
Shirom-Melamed Burnout Questionnaire (SMBQ). The question-
naire includes 22 items measuring different aspects of burnout
syndrome, including physical fatigue, emotional exhaustion,
tension, listlessness and cognitive weariness as defined by Melamed
and co-workers [15]. The SMBQ correlates strongly with the
Maslach Burnout Inventory, another widely used instrument for
measurement of burnout, and a mean score above 3.75 was used
as a cut-off to define high burnout based on quartile splits [16].
Stenlund and co-workers reported the mean score of the total scale
in patients with burnout to be 5.7 for females and 5.6 for males
[17]. In this study, the median value of the SMBQ score for the
total population (controls and patients) was used as cut-off to
define high burnout. The median value was 4.3 in part one
(N=84) and 4.0 in part two (N=177).
Samples and Measurements
Fasting blood samples were collected in EDTA tubes during the
patient’s first visit to the clinic, before onset of treatment and all
samples were taken before 09:30 AM. Healthy controls also visit
the clinic in the morning for fasting blood sampling. Plasma was
obtained by centrifugation of the blood samples at 4uC for
15 minutes at 1250 g and stored at 280uC before analysed.
Cytokines and growth factors. Plasma concentrations of
epidermal growth factor (EGF), monocyte chemotactic protein-1
(MCP-1), vascular endothelial growth factor (VEGF), interleukin-
1alpha (IL-1a), interleukin-1beta (IL-1b), interleukin-2 (IL-2),
interleukin-4 (IL-4), interleukin-6 (IL-6), interleukin-8 (IL-8),
interleukin-10 (IL-10), tumour necrosis factor-alpha (TNF-a) and
interferone-gamma (IFN-c) were assessed using an automated
immunoassay system, Evidence, based on protein biochip array
technology (Randox Laboratories Ltd, Crumlin, UK). The
technique is by Fitzgerald et al [18]. All samples were analyzed
in duplicates.
Comparing different analytic techniques to measure
cytokines and growth factors. Optimal cut off values of
MCP-1, EGF and VEGF for subjects at risk of being classified as
ill were suggested by Asberg et al [11]. In order to use strictly
defined cut-off values, similar results must be obtained even when
different analytic measures are used. The initial analyses in this
study were performed using a biochip immunoassay system from
the same manufacturer (Randox Laboratories Ltd) as in the
Asberg study [11]. The plasma levels of MCP-1 and VEGF were
thus reanalyzed using the Meso Scale Delivery (MSD) Technology
(Gaithersburg, Maryland). This was done eight months later, using
the same samples, stored at 280uC until analysed and only
individuals (both patients and controls) with valid measure from
both analyses were included in the statistical analysis (n=83 for
Table 3. Descriptive data for subjects included in the second
part of the study (CRP measurement).
Patients
(n=89)
Controls
(n=88) p-value
Age (years)
¤ 40.966.7 44.668.5 0.006
Sex (% male)
# 48% 50% 0.822
BMI (kg/m
2)
¤ 24.363.0 23.762.4 0.198
Burnout score
¤ 5.360.85 2.360.88 ,0.001
- Percent scoring .4.3 on burnout 92% 6%
Percent with depression 73% 0%
(clinical diagnoses)
Percent with anxiety 75% 0%
(clinical diagnoses)
HAD Depression Score
# ,0.001
0–6 34% 94%
7–10 33% 6%
.10 32% 0%
HAD Anxiety Score
# ,0.001
0–6 11% 83%
7–10 24% 11%
.10 64% 6%
¤Mann-Whitney test, data presented as mean and SD.
#Chi-square test, data presented as percentage within each scoring group.
doi:10.1371/journal.pone.0007659.t003
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protein was not included in the MSD platform.
CRP measurements. CRP levels were measured from
serum by using turbidimetric analysis (Roche, Basel, Switzerland).
Statistical Analysis
Statistical analyses of cytokines and CRP in plasma and serum
were performed using Mann-Whitney unpaired non-parametric
test. Differences in plasma levels of MCP-1 and VEGF obtained
using RANDOX and MSD platforms were analyzed using
Wilcoxon sign-ranked test. The concurrence between the two
platforms was analysed using 95% limits of agreement. No data
imputation was done and cytokines or growth factors with more
than 50% non-detectable values were not considered meaningful
to statistically analyse. Differences in depression and anxiety scores
were assessed using chi-square test. For all tests, p,0.05 was
considered statistically significant.
Results
Patients with Stress-Related Exhaustion Do Not Have
Altered Cytokine Profile
The plasma levels of IL-1a, IL-1b, IL-2, IL-4, IL-6, IL-8, IL-10,
IFNc, TNFa, MCP-1, EGF and VEGF from female patients with
ED and control subjects were analysed (n=42+42). Due to the
high number of non-detectable values, IL-1a (70% missing values),
IL-4 (77% missing values), IL-10 (54% missing values) and IFNc
(70% missing values) where not considered meaningful to
statistically analyse. No difference was seen between the controls
compared to the patient group regarding the numbers of
individuals with non-detectable values.
For IL-1b (24 controls and 25 patients), IL-2 (20 controls and 24
patients), IL-6 (33 controls and 28 patients), IL-8 (37 controls and
26 patients) and TNFa (42 controls and 40 patients) no statistical
differences were seen between patients and controls (data not
shown). For MCP-1, EGF and VEGF, no significant differences
were observed between the two groups (Table 4). MCP-1, EGF
and VEGF levels were further investigated in relation to the
measures of self-reported depression, anxiety and burnout
irrespective of the ED diagnose. Thus, both patients and control
subjects were included in these analyses and divided into groups of
high and low burnout according to the median split of SMBQ
score as well as high and low anxiety and depression levels
according the HAD scale recommended score for cases of anxiety
disorder and depression (.10). No significant difference was seen
between the groups for any of the analysis (Table 4). However,
with p values of 0.083 for the anxiety score and 0.091 for
depression, a trend can be seen that the high scoring cohorts
actually tend to have lower MCP-1, which further contradicts
the suggested biomarker function showed by Asberg and co-
workers [11].
We also checked the impact of self-reported physical activity (4
graded scale), completed by 75 of the 84 subjects included in the
study. No difference was seen between the different activity groups
indicating that the level of physical activity does not contribute to
the results. The use of nicotine did not influence the cytokine or
growth factor levels either, nor did consumption of antidepres-
sants.
Re-analysing the plasma levels of MCP-1 and VEGF from
patients and controls by using the MSD platform revealed
significantly higher median levels for both MCP-1 (N=83) and
for VEGF (N=65) compared to the median level obtained by
using the RANDOX platform (Figure 1). Similar to the results
from the RANDOX platform, no significant differences were
observed between patients and healthy controls (data not shown).
The discrepancy between the two platforms was analysed using
95% limits of agreement test [19]. When comparing the MCP-1
levels measured with the MSD platform with the levels obtained
using the RANDOX platform, the mean difference was 131 pg/ml,
with 95% limits of agreement ranging from 264 to 326 pg/ml. For
VEGF, the mean difference was 34 pg/ml and the 95% limits of
agreement ranged from 26 to 75 pg/ml.
Patients with Stress-Related Exhaustion Have Increased
Serum Levels of CRP
Although no differences in plasma levels of cytokines were
observed between patients with exhaustion and control subjects,
the degree of inflammation were further analyzed by measuring
the inflammatory marker CRP in another group of patients
fulfilling the diagnostic criteria for ED. The patients did have a
significantly higher serum CRP concentration compared to
healthy control subjects (Figure 2). The level of CRP was not
Table 4. Plasma levels (pg/ml) of MCP-1, VEGF and EGF in relation to Exhaustion disorder (ED) diagnosis, degree of burnout,
anxiety and depression in female patients and healthy controls.
Control Patient Burnout Burnout Anxiety Anxiety Depression Depression
,4.3 $4.3 score #10 score .10 score #10 score .10
MCP-1 115618.6 11767.49 111618.7 12267.43 119615.8 10268.67 118611.9 92.3612.0
(42) (41) (42) (41) (49) (34) (68) (15)
p=0.771 p=0.978 p=0.083 p=0.091
EGF 5.9361.03 6.3165.04 6.4761.07 5.4265.08 5.1261.02 8.3765.23 5.5461.35 7.1168.70
(25) (19) (25) (19) (26) (18) (34) (10)
p=0.696 p=0.991 p=0.272 p=0.300
VEGF 8.9866.20 11.661.54 10.665.99 10.461.62 9.2365.26 10.761.76 11.363.73 9.0361.99
(33) (37) (34) (36) (39) (31) (56) (14)
p=0.259 p=0.747 p=0.332 p=0.445
Data are presented as median and standard error of the mean (SEM).
Due to the high number of non-detectable values, the number of observations varies and is listed within parenthesis for each measurement.
P values are given for respective analysis between the groups.
doi:10.1371/journal.pone.0007659.t004
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(data not shown) and no difference was observed between patients
using antidepressants and other patients (data not shown).
Discussion
In this study, we measured the plasma levels of several cytokines
and growth factors in patients with stress-related exhaustion and
healthy controls. We found no statistically significant differences
between the groups for any of the proteins measured. Thus, we
were unable to replicate the findings by Asberg and co-workers
suggesting that MCP-1, EGF and VEGF may be markers of long-
term psychosocial stress [11]. Furthermore, using the measures of
high burnout, depression or anxiety instead of exhaustion did not
change this conclusion, since none of these measures were
associated with the suggested markers of long-term stress.
There are several issues concerning the validity of cytokines and
growth factors as stress markers. An important consideration is
the large inter-individual variation in both ours and the previous
study [11]. Furthermore, the circadian rhythm affects MCP-1
[20], VEGF [21] and EGF [22] levels and age is also known
to affect circulating levels of several cytokines [23]. Elevated
MCP-1 has been shown to be associated with depression [24],
chronic pain diagnosis such as fibromyalgia [25] and chronic
inflammatory diseases such as rheumatic arthritis [26]. In
addition, plasma levels of MCP-1 are affected by a polymorphism
in the MCP-1 gene [27].
Interestingly, we did not find an association between MCP-1
and depression as previously reported [28]. On the contrary we
found a trend for a lower MCP-1 value with higher scores of both
anxiety and depression. A majority of our patients fulfilled
diagnostic criteria for depression but it is possible that these
patients are somewhat different from other patient populations
with depression since exhaustion is the most dominant clinical
feature of the patients included in this study, and both depression
and anxiety could be secondary to the exhaustion. This, however,
remains to be thoroughly studied. Also, we noticed that it seems to
be an discrepancy between the number of patients fulfilling the
criteria for depression and those scoring above ten on self-reported
scale for depression (HAD), but self-reported anxiety seems to be
more congruent with the clinical diagnose. This need to be further
studied in future work on these patients.
The Asberg study suggested that cut-off values of 243 pg/ml for
MCP-1 and 7.80 pg/ml for VEGF could be used to predict the
likelihood of being classified as ill due to long-term stress responses
[11]. If this is to be generalized it is required that similar levels are
obtained regardless of the analytic method used. We found that
the average values of MCP-1 for the whole group were 117 and
249 pg/ml using the RANDOX and MSD platforms respectively,
and for VEGF the average values were 11 and 42 pg/ml
respectively. If the suggested cut-off values are applied on the
MSD platform generated data in this study, all healthy controls
would have been classified as ill according to their VEGF levels,
and 64% according to their MCP-1 levels. The discrepancy in
protein levels between the two platforms could be explained by
several factors, such as the generation and purity of antibodies and
reference proteins (different species or different techniques), the
range of the standard curve, technical differences of the platforms
and analysis sensitivity and specificity. Besides the difference in
protein levels, the 95% limit of agreement between the two
methods showed that the distribution of difference was very wide,
indicating a high variability between the two different measure-
ments which is rather remarkable since the same plasma samples
were analysed. Given that these two analytic techniques show such
a difference when samples from the same individuals are measured
indicates that comparing absolute values between two different
studies might not be possible. It seems more suitable to present
data as a magnitude of change in relation to control levels and any
general cut-off values for risk of illness might not be possible to use.
Although there were no differences in plasma levels of cytokines,
we wanted to further investigate possible differences in inflamma-
tory status between patients with exhaustion and controls. We
Figure 1. Plasma levels of MCP-1 and VEGF using different
platforms. Plasma levels of MCP-1 (n=83) and VEGF (N=65) from
patients and healthy controls measured using two different analysing
methods. Using the MSD platform yielded significantly higher levels of
both MCP-1 (2.1-fold) and VEGF (3.7-fold) compared to the RANDOX
platform. Data are presented as median and SEM. *** p,0.001
doi:10.1371/journal.pone.0007659.g001
Figure 2. Serum levels of CRP. Serum levels of inflammatory marker
CRP were significantly higher (1.4-fold) in patients with Exhaustion
Disorder (n=89) compared with control subjects (n=88). Data
presented as median and SEM. * p=0.02
doi:10.1371/journal.pone.0007659.g002
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of CRP, which is in line with a previous study reporting correlation
between CRP and degree of burnout in women [29], which could,
however, not be confirmed in a smaller study [16]. CRP has also
been associated with long-term stress [30] as well as with
depression [31,32] but data is not consistent [33]. The increased
levels of CRP found in the patients in this study suggest that there
could be a relation between long-term stress and low-grade
inflammation and calls for more studies to confirm this. CRP has
been shown to increase with age [34] but since the control subjects
were a few years older, higher age does probably not account for
this difference. There were no differences in gender or BMI
between the groups and additional analysis using logistic
regression confirmed that neither age, BMI nor gender contrib-
uted to the differences between the two groups.
There are several limitations that may affect the outcome of our
study, one being the rather small number of patients included
compared to the previous study by Asberg, as well as different
characteristics of the populations studied [11]. This could partly
explain the discrepancy of the results but if MCP-1, EGF and
VEGF are to be used as stable markers of stress, they should be
able to discriminate patients from controls even in smaller groups.
Like in the previous study the measurements included was based
on only one single blood sample. Several factors, such as nutrition,
nicotine consumption, medication and physical activity should be
controlled for when inflammation markers are studied. Informa-
tion regarding most of these factors was available in this study and
none were seen to affect the results.
In summary we conclude that MCP-1, EGF and VEGF may
not be suitable as markers of prolonged psychosocial stress.
However, low-grade inflammation seem to be present in patients
suffering from exhaustion due to long-term psychosocial stress and
it is plausible that some markers related to inflammation can be
used as future stress markers. The large discrepancy between
protein levels of suggested markers, measured with two different
proteins assays, raises the question of using absolute values when
comparing studies in which different analytic methods have been
used.
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